Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3737 Target Snapshot

5-hydroxytryptamine receptor 1A · SINGLE PROTEIN · Mus musculus

127Compounds
50Assays
4Approved Drugs
110.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt Q64264. Use UniProt Q64264 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q64264 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats 5-hydroxytryptamine receptor 1A as ChEMBL target CHEMBL3737, mapped to UniProt Q64264. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
5-hydroxytryptamine receptor 1A
SINGLE PROTEIN · Mus musculus
As of 2026-09-13
ChEMBL target ID
CHEMBL3737
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
Q64264
5-hydroxytryptamine receptor 1A
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether 5-hydroxytryptamine receptor 1A is the right protein anchor across sources, using UniProt Q64264 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein Label5-hydroxytryptamine receptor 1A
UniProt AccessionQ64264
Component TypeProtein
Sequence Length421 aa

5-hydroxytryptamine receptor 1A

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as 5-hydroxytryptamine receptor 1A, mapped to UniProt Q64264. Sequence length is 421 aa.

Mapped IDQ64264
Review name5-hydroxytryptamine receptor 1A
OrganismMus musculus
Clinical Profile

Clinical Phase Distribution

4
Approved
1
Phase III
2
Phase II
Assay Mix

Activity Type Distribution

IC5039.0
KI70.0
EC501.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL10270 9.7 Ki 0.2 Preclinical
CHEMBL63449 9.7 Ki 0.2 Preclinical
CHEMBL65274 9.7 Ki 0.2 Preclinical
CHEMBL26118 9.4 Ki 0.4 Preclinical
CHEMBL26998 9.3 Ki 0.5 Preclinical
CHEMBL3946661 9.22 Ki 0.6 Preclinical
CHEMBL28437 9.1 Ki 0.8 Preclinical
CHEMBL141438 8.89 IC50 1.3 Preclinical
CHEMBL2021539 8.89 Ki 1.3 Preclinical
CHEMBL356743 8.72 IC50 1.9 Preclinical
Distribution

pChEMBL Value Distribution

9
5.0
7
5.5
12
6.0
6
6.5
5
7.0
3
7.5
17
8.0
8
8.5
4
9.0
3
9.5
pChEMBL
Approved Drugs

Approved Drugs

ILOPERIDONE
CHEMBL14376
Approved 2009
RISPERIDONE
CHEMBL85
Approved 1993
SUMATRIPTAN
CHEMBL128
Approved 1992
Assay Landscape

Assay Landscape

50
Total Assays
77
Tested Compounds
2
Assay Types
Binding — 36 assays, 77 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 23 41 7.7
tissue-based format 6 6 4.8
cell-based format 4 7 7.8
organism-based format 2 4 7.9
assay format 1 19 6.0
Functional — 14 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
organism-based format 9 0
assay format 5 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine